Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| So, this is for sure an area we will continue to expand and will deliver opportunities for a lot of value to our customers that deploy not just front-end, but also customer service |
| We believe this success provides additional confidence in our ability to meet or exceed our synergy targets for the Acclara deal |
| So, we are confident as we execute on these areas, we will deliver for our customers, first and foremost, and deliver sustainable growth, EBITDA and cash flow for our shareholders |
| Two is expanding our market position with new customers, including Providence and other new modular wins |
| We're performing well for the largest, most mature customers |
| What I want to say in closing is we believe we've established a solid foundation for future growth and performance |
| Look, the reason I am excited, Stephanie, and the team is very excited, is we see a massive value unlock for our customers and shareholders on deploying large language models into our systems, tools and technology |
| This also brings the potential for higher blended margins while establishing embedded opportunities to expand into an end-to-end partnership in the future |
| Automating, summarizing charts and deploying that in our coding business has immediate value to customers on accelerating cash collections and value related to our cost structure |
| We feel very good about that partnership |
| We believe these efforts will create new opportunities to deliver increased value to our customers, further reduce our operating costs and enhance our growth |
| It has been a productive year and one where I believe we have made significant progress and have built a solid foundation for sustainable growth and strong financial performance over the coming years |
| But this area gives us a lot of confidence on more rapid deployment of products, shipping new products to our customers into our operating systems, and it's just something we're very excited about |
| We delivered $2.25 billion in revenue, strong adjusted EBITDA of approximately $614 million, with adjusted EBITDA margins of 27% |
| We delivered double-digit growth driven by the full ramp of new end-to-end customers and continued strong performance in our modular solutions |
| This growth highlights the market demand for our solutions and our ability to effectively leverage our global operating scale |
| As we outlined in our earnings release, our 2024 outlook reflects continued underlying growth across R1's business, including low single-digit growth in our existing end-to-end customer base, offset by customer facility divestitures and previously disclosed customer attrition, as well as continued double-digit growth in our modular revenue |
| As we deploy these models and we see opportunities to be able to automate that, we'll be able to grow, and the incremental margin on that will be much higher |
| We're still in the early days, so we're monitoring it very closely, but we feel very good about the opportunity there |
| Continued strength in our modular bookings, combined with the acquisition of Acclara and the Providence end-to-end deal demonstrates our continued ability to drive growth as well as increased diversification within our business |
| The acquisition of Acclara and resulting 10-year partnership with Providence represents a significant growth opportunity and marks the first cross-sell of an operating partner relationship into the Cloudmed base |
| But you'll hear me and Jennifer talk more and more about the adoption of AI, which in turn drives greater revenue yield, lower cost, and just generally increased customer satisfaction and confidence in our growth rates and margin expansion |
| In addition, R1 has already seen initial traction for a go-to-market activity leveraging our flexible model, which we believe will add new opportunities in the near term with solid embedded growth potential over time |
| So, let me just step back and say, look, we, the team feel very good about the fundamental growth prospects for the entire business, okay? That said, we have talked a lot in my first year as CEO about the end-to-end business, and today we have a much more diversified business, right? A lot less customer concentration, the Cloudmed business, plus the legacy modular business is a much more substantial part of our business |
| But overall, feel very good about both the quality of the business, the receptiveness of the marketing customers for those solutions and our synergy targets |
| But we have a healthy pipeline on both the end-to-end side, and I expect another strong year of bookings on the Cloudmed and R1 modular side |
| A couple of advantages, if you will, of that deployment is it was a centralized revenue cycle, strong executive leadership and support |
| So, good across all fronts, end-to-end, modular |
| Third, as I mentioned, legacy Cloudmed solutions have been and will continue to be a key driver for the company's growth and profitability, accelerating our technology roadmap and enhancing our opportunity with a larger potential customer base |
| In addition, the synergy realization from the Cloudmed integration is progressing very well |
| Statement |
|---|
| Now, that said, take one metric, Jailendra, HDR, which is a challenge across the industry |
| And based on the upfront investment for the ramp of the Providence new business, we expect the Providence contract to have a negative impact on adjusted EBITDA of approximately $45 million in 2024 |
| Non-GAAP cost of services in Q4 was approximately $358 million, down $6.8 million year-over-year and down nearly $7 million from the prior quarter |
| So, just to give you the high level on metrics, post COVID, clearly there's been more payer pressure, changes in timelines on payments |
| And then Acclara with the integration, we expect that it will be a drag on free cash flow in 2024, as we have transaction costs in the first half of the year, we have higher interest expense associated with the debt, and we're going to be integrating the business and realizing costs associated with synergies as we begin to execute on that |
| The year-over-year decrease was primarily driven by margin maturity across customers onboarded in 2022 combined with synergy realization from the Cloudmed acquisition |
| Customer attrition is related to APP and pediatrics as well as the impact of facility divestitures we expect for two customers, including several AMITA Health hospitals which were part of the Ascension and AdventHealth JV dissolution as announced in 2022 |
| We accomplished all of this while addressing several challenges in the base business, which are reflected in our 2024 outlook |
| Just curious if that's still the case or if you're seeing any signs of it getting particularly better or worse |
| It looks like those stepped down sequentially in the fourth quarter |
| On incentive fees, last quarter, we had some one-time items that increased our incentive fees in the quarter, and so we had reflected that we knew we would have a decrease quarter-over-quarter in incentive fees |
| So, what I would say, Jailendra, is we are not done on performing for our customers |
| There is a high level of end market demand in both end-to-end managed services and Cloudmed, macro growth across the industry and needs, especially for providers who may be struggling with financial pressure, high labor, inconsistent adoption of technology, payer pressure, et cetera |
| Our results and our outcomes may differ materially from those included in these forward-looking statements and as a result of various factors, including, but not limited to, economic downturns and market conditions beyond our control, including high inflations, the quality of global financial markets, or the ability to timely and successfully achieve the anticipated benefits of potential synergies of the acquisitions of Cloudmed and Acclara, our ability to retain existing customers or acquire new customers, the development of markets for our revenue cycle management offering, variability in lead time of prospective customers, competition within the market and factors discussed under the heading Risk Factors in our most recent annual report on Form 10-K |
| Excluding the impact of the provision, SG&A expenses were down 7% year-over-year, driven by synergy realization, offset by investments we are making in technology |
| All forward-looking statements made on today's call involve risks and uncertainties |
| The increasing challenges faced by providers has heightened their need for partners that can be flexible in how they deliver value over time |
| Obviously, a lot of moving parts here with customers coming in and out and some pause here on the Sutter side |
| Our guidance assumes that will be improved off of 2023, but I do think it will still be a bit elevated from a historical number |
| I don't think there's going to be significant improvement in payer timelines |
Please consider a small donation if you think this website provides you with relevant information